Medicare Enrolled

Dr. James McKiernan, MD

Urology Physician · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
161 FORT WASHINGTON AVE, New York, NY 10032
2123050114
Registered in NPPES since 2006
NPI: 1891804746 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McKiernan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McKiernan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McKiernan

Dr. James McKiernan is an urology physician in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. McKiernan performed 375 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. McKiernan received a total of $8,087 from 23 pharmaceutical and/or device companies across 77 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McKiernan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 375 Medicare services $8,087 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
375
Medicare services
Bottom 22% in NY for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$162
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
147 $219 $1,500
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
131 $113 $530
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
39 $75 $650
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
16 $157 $7,180
Bladder tumor removal via endoscope
This procedure involves using an endoscope to destroy or remove a large growth from the bladder.
15 $347 $2,390
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $153 $740
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $78 $380
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,087
Total received (2018-2024)
Avg $1,155/year across 7 years
Top 21% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
77
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,987
2023
$260
2022
$438
2021
$79
2020
$134
2019
$386
2018
$3,803

Payments by company (2024)

UROGEN PHARMA, INC.
$2,650
Sumitomo Pharma America, Inc.
$180
ABBVIE INC.
$79
Photocure Inc
$42
Ambu Inc.
$37
Top 3 companies account for 97.4% of 2024 payments
All-time payments by company (2018-2024) ›
Fidia Pharma USA Inc.
$3,200
UROGEN PHARMA, INC.
$2,650
Photocure Inc
$308
Astellas Pharma US Inc
$266
Sumitomo Pharma America, Inc.
$249
Janssen Biotech, Inc.
$244
Janssen Scientific Affairs, LLC
$183
Ambu Inc.
$145
EDAP TECHNOMED INC
$121
TOLMAR Pharmaceuticals, Inc.
$118
Blue Earth Diagnostics Limited
$111
ABBVIE INC.
$110
Coloplast Corp
$95
UroGen Pharma, Inc.
$88
Hollister Incorporated
$32
180 Medical, Inc.
$28
Boston Scientific Corporation
$28
UROVANT SCIENCES INC
$27
Palette Life Sciences, Inc.
$23
PFIZER INC.
$20
Sagent Pharmaceuticals, Inc.
$15
Ferring Pharmaceuticals Inc.
$14
AbbVie, Inc.
$13
Top 3 companies account for 76.1% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · Axumin · BOTOX · CYSVIEW · Cysview · Deflux · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · General - Kidney Stone Disease · Glydo · Isiris aStent Removal Device · JELMYTO · Lupron · MYRBETRIQ · Oncofid · SELF-CATH · SPEEDICATH · VaPro · XTANDI · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an urology physician in New York?
Compare urology physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians in nearby ZIP areas
751
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McKiernan is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McKiernan experienced with cystourethroscopy?
Based on Medicare claims data, Dr. McKiernan performed 147 cystourethroscopy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McKiernan receive payments from pharmaceutical companies?
Yes. Dr. McKiernan received a total of $8,087 from 23 companies across 77 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McKiernan's costs compare to other urology physicians in New York?
Dr. McKiernan's average Medicare payment per service is $162. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McKiernan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →